COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,235 Articles (22,733 medRxiv, 8,502 bioRxiv)

Most recent first Previous |  Page 552: Articles 5511-5520  | Next

Discovering Social Determinants of Health from Case Reports using Natural Language Processing: Algorithmic Development and Validation
Raza, S.
10.1101/2022.11.30.22282946 — Posted: 2022-12-05
Healthcare in England was affected by the COVID-19 pandemic across the pancreatic cancer pathway: a cohort study using OpenSAFELY-TPP
Lemanska, A., Andrews, C. D., Fisher, L., Bacon, S., Mehrkar, A., Inglesby, P., Davy, S., Patalay, P., Goldacre, B., MacKenna, B., The OpenSAFELY Collaborative, , Walker, A. J.
10.1101/2022.12.02.22283026 — Posted: 2022-12-05
Cyclic lipopeptides as membrane fusion inhibitors against SARS-CoV-2: new tricks for old dogs
Shekunov, E. V., Zlodeeva, P. Z., Efimova, S. S., Muryleva, A. A., Zarubaev, V. V., Slita, A. V., Ostroumova, O. S.
10.1101/2022.12.05.519140 — Posted: 2022-12-05
High resolution cryo-EM structures of two potently SARS-CoV-2 neutralizing monoclonal antibodies of same donor origin that vary in neutralizing Omicron variants
Rencilin, C. F., Ansari, M. Y., Chatterjee, A., Deshpande, S., Mukherjee, S., Singh, R., Jayatheertha, S., Reddy, P. M., Das, P., Hingankar, N., Rathore, D., Varadarajan, R., Bhattacharya, J., Dutta, S.
10.1101/2022.12.03.518949 — Posted: 2022-12-05
DiffDomain enables identification of structurally reorganized topologically associating domains
Hua, D., Gu, M., Zhang, X., Du, Y., Xie, H., Qi, L., Du, X., Bai, Z., Zhu, X., Tian, D.
10.1101/2022.12.05.519135 — Posted: 2022-12-05
Covidscope: An atlas-scale COVID-19 resource for single-cell meta analysis at sample and cell levels
Yin, D., Cao, Y., Chen, J., Mak, C. L. Y., Yu, K. H. O., Lin, Y., Ho, J. W. K., Yang, J. Y. H.
10.1101/2022.12.03.518997 — Posted: 2022-12-05
Cryo-EM structure of SARS-CoV-2 postfusion spike in membrane
Shi, W., Cai, Y., Zhu, H., Peng, H., Voyer, J., Rits-Volloch, S., Cao, H., Mayer, M. L., Song, K., Xu, C., Lu, J., Zhang, J., Chen, B.
10.1101/2022.12.05.519151 — Posted: 2022-12-05
Convergent evolution of the SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant
Ito, J., Suzuki, R., Uriu, K., Itakura, Y., Zahradnik, J., Deguchi, S., Wang, L., Lytras, S., Tamura, T., Kida, I., Nasser, H., Shofa, M., Begum, M. M., Tsuda, M., Oda, Y., Fujita, S., Yoshimatsu, K., Ito, H., Nao, N., Asakura, H., Nagashima, M., Sadamasu, K., Yoshimura, K., Yamamoto, Y., Nagamoto, T., Schreiber, G., The Genotype to Phenotype Japan (G2P-Japan) Consortium, , Saito, A., Matsuno, K., Takayama, K., Tanaka, S., Fukuhara, T., Ikeda, T., Sato, K.
10.1101/2022.12.05.519085 — Posted: 2022-12-05
Enhanced Protection from SARS-CoV-2 Variants by MVA-Based Vaccines Expressing Matched or Mismatched S Proteins Administered Intranasally to hACE2 Mice
Cotter, C. A., Americo, J. L., Earl, P. L., Moss, B.
10.1101/2022.12.03.518963 — Posted: 2022-12-05
Deep mutational scanning to predict antibody escape in SARS-CoV-2 Omicron subvariants
Alcantara, M. C., Higuchi, Y., Kirita, Y., Matoba, S., Hoshino, A.
10.1101/2022.12.02.518937 — Posted: 2022-12-05

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).